Hypoxia-Inducible Factors: Master Regulators of Cancer Progression

被引：700

作者：

Schito, Luana ^{[1
]}

Semenza, Gregg L. ^{[2
,3
,4
,5
,6
,7
]}

机构：

[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada

[2] Johns Hopkins Univ, Sch Med, Inst Cell Engn, McKusick Nathans Inst Genet Med, Baltimore, MD 21218 USA

[3] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA

[4] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA

[5] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA

[6] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD 21218 USA

[7] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA

来源：

TRENDS IN CANCER | 2016年 / 2卷 / 12期

关键词：

oxygen biology; tumor microenvironment;

D O I：

10.1016/j.trecan.2016.10.016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Intratumoral hypoxia (reduced O-2 availability) is a common finding in human cancer and leads to increased activity of hypoxia-inducible factors (HIFs), which regulate the expression of genes that contribute to angiogenesis, metabolic reprogramming, extracellular matrix remodeling, epithelial-mesenchymal transition, motility, invasion, metastasis, cancer stem cell maintenance, immune evasion, and resistance to chemotherapy and radiation therapy. Conventional anticancer therapies target well-oxygenated and proliferating cancer cells, whereas there are no approved therapies that target hypoxic cancer cells, despite growing clinical and experimental evidence indicating that intratumoral hypoxia is a critical microenvironmental factor driving cancer progression. In this review, our current understanding of the consequences of HIF activity and the translational potential of targeting HIFs for cancer therapy are discussed.

引用

页码：758 / 770

页数：13

共 90 条

[1] A Mechanism of Hypoxia-Mediated Escape from Adaptive Immunity in Cancer Cells
Barsoum, Ivraym B.
Smallwood, Chelsea A.
Siemens, D. Robert
Graham, Charles H.
[J]. CANCER RESEARCH, 2014, 74 (03) : 665 - 674
[2] Hypoxia inducible factor-1 is activated by transcriptional co-activator with PDZ-binding motif (TAZ) versus WWdomain-containing oxidoreductase (WWOX) in hypoxic microenvironment of bone metastasis from breast cancer
Bendinelli, Paola
Maroni, Paola
Matteucci, Emanuela
Luzzati, Alessandro
Perrucchini, Giuseppe
Desiderio, Maria Alfonsina
[J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 (11) : 2608 - 2618
[3] Fatty Acid Uptake and Lipid Storage Induced by HIF-1α Contribute to Cell Growth and Survival after Hypoxia-Reoxygenation
Bensaad, Karim
Favaro, Elena
Lewis, Caroline A.
Peck, Barrie
Lord, Simon
Collins, Jennifer M.
Pinnick, Katherine E.
Wigfield, Simon
Buffa, Francesca M.
Li, Ji-Liang
Zhang, Qifeng
Wakelam, Michael J. O.
Karpe, Fredrik
Schulze, Almut
Harris, Adrian L.
[J]. CELL REPORTS, 2014, 9 (01): : 349 - 365
[4] Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases
Carmeliet, Peter
Jain, Rakesh K.
[J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (06) : 417 - 427
[5] Cerulean Pharma, 2016, CER ANN RES PHAS 2 C
[6] MicroRNA-210 Controls Mitochondrial Metabolism during Hypoxia by Repressing the Iron-Sulfur Cluster Assembly Proteins ISCU1/2
Chan, Stephen Y.
Zhang, Ying-Yi
Hemann, Craig
Mahoney, Christopher E.
Zweier, Jay L.
Loscalzo, Joseph
[J]. CELL METABOLISM, 2009, 10 (04) : 273 - 284
[7] Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression
Chang, Chih-Hao
Qiu, Jing
O'Sullivan, David
Buck, Michael D.
Noguchi, Takuro
Curtis, Jonathan D.
Chen, Qiongyu
Gindin, Mariel
Gubin, Matthew M.
van der Windt, Gerritje J. W.
Tonc, Elena
Schreiber, Robert D.
Pearce, Edward J.
Pearce, Erika L.
[J]. CELL, 2015, 162 (06) : 1229 - 1241
[8] Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
Chaturvedi, Pallavi
Gilkes, Daniele M.
Takano, Naoharu
Semenza, Gregg L.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (20) : E2120 - E2129
[9] Targeting renal cell carcinoma with a HIF-2 antagonist
Chen, Wenfang
Hill, Haley
Christie, Alana
Kim, Min Soo
Holloman, Eboni
Pavia-Jimenez, Andrea
Homayoun, Farrah
Ma, Yuanqing
Patel, Nirav
Yell, Paul
Hao, Guiyang
Yousuf, Qurratulain
Joyce, Allison
Pedrosa, Ivan
Geiger, Heather
Zhang, He
Chang, Jenny
Gardner, Kevin H.
Bruick, Richard K.
Reeves, Catherine
Hwang, Tae Hyun
Courtney, Kevin
Frenkel, Eugene
Sun, Xiankai
Zojwalla, Naseem
Wong, Tai
Rizzi, James P.
Wallace, Eli M.
Josey, John A.
Xie, Yang
Xie, Xian-Jin
Kapur, Payal
McKay, Renee M.
Brugarolas, James
[J]. NATURE, 2016, 539 (7627) : 112 - +
[10] Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
Chiche, Johanna
Brahimi-Horn, M. Christiane
Pouyssegur, Jacques
[J]. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (04) : 771 - 794

← 1 2 3 4 5 6 7 8 9 →